The Stroke Diagnostics and Therapeutics Market was valued at USD 37.5 billion in 2023 and is projected to expand significantly, reaching USD 73.3 billion by 2032 with a CAGR of 7.74% during the forecast period from 2024 to 2032. This growth is driven by advancements in diagnostic technologies, rising awareness about stroke management, and an increasing focus on preventive healthcare measures.Key..